AIDS Research and Treatment
Volume 2014 (2014), Article ID 267450, 7 pages
http://dx.doi.org/10.1155/2014/267450

Research Article

Establishment of Normal Reference Intervals for CD3⁺, CD4⁺, CD8⁺, and CD4⁺ to CD8⁺ Ratio of T Lymphocytes in HIV Negative Adults from University of Gondar Hospital, North West Ethiopia

Addisu Gize,¹ Biniam Mathewos,² Beyene Moges,² Meseret Workineh,² and Lealem Gedefaw¹

¹Department of Medical Laboratory Science and Pathology, Jimma University, Jimma, Ethiopia
²Department of Immunology and Molecular Biology, College of Medicine and Health Sciences, University of Gondar, Ethiopia

Received 26 August 2014; Revised 30 October 2014; Accepted 31 October 2014; Published 18 November 2014

Academic Editor: P. K. Nicholas

Copyright © 2014 Addisu Gize et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Reference values for the CD3⁺, CD4⁺, CD8⁺, and CD4⁺ to CD8⁺ ratio T lymphocyte subsets are adopted from textbooks. But for appropriate diagnosis, treatment, and follow-up of patients, correct interpretations of the laboratory results from normal reference interval are mandatory. This study was, therefore, planned to establish normal reference interval for T lymphocytes subset count and CD4⁺ to CD8⁺ ratio. Methods. A cross-sectional study was conducted on apparently healthy adult individuals who visited voluntary counseling and HIV testing clinic Gondar University Hospital from April to May, 2013. Whole blood was analyzed using fluorescence-activated cell sorting (BD FACS, San Jose, CA) machine to enumerate the T-cell subpopulations. Results. Out of the total 320 study participants, 161 (50.3%) were men and 159 (49.7%) were women. The normal reference intervals were (655–2,823 cells/μL), (321–1,389 cells/μL), and (220–1,664 cells/μL) for CD3⁺, CD4⁺, and CD8⁺ T lymphocyte subsets, respectively, and CD4⁺ to CD8⁺ ratio was 0.5–2.5. Conclusion. The overall CD3⁺ T lymphocytes reference interval in the current study was wide; low CD4⁺ T lymphocytes, CD4 to CD8 ratio, and high CD8⁺ T lymphocytes values were observed.

1. Introduction

T lymphocyte cells are defined by the expression of molecules. The most important cell-surface molecules for identifying T lymphocyte subpopulations have been , , and T-cell receptor complex molecules (, the T-cell receptor α and β chains [1].

Those cells which express and CXCR4 cell-surface molecules serve as a receptor and coreceptor for human immunodeficiency virus (HIV), respectively. HIV infects T lymphocytes mainly, replicates within them, and lyses the cells as the replicated virions are released extracellularly to infect yet other cells [2].

In advanced disease, most of the observed immune defects can ultimately be explained by the quantitative depletion of T lymphocytes and the severity is reflected by measures of the absolute T lymphocyte numbers per blood volume, the percentages of lymphocyte (%) among lymphocytes, and also the / ratio [3].

T lymphocyte cells coordinate the immune system’s response to the pathogens [4], and hence, normal reference interval values are critically important for the correct interpretation of diagnostic tests [5]. The influence of geographical location, racial and ethnic background, age, sex, and conditions of living on the distribution of human peripheral blood T lymphocyte subpopulations has already been documented in various studies of a given population in different parts of the world [6–8].

Few studies conducted in Africa show significant reference range variations of T-cell and T-cells within African populations because of environmental, sociodemographic differences and because of biological influences such as age, altitude, and ethnic origin [9–12].

Ethiopia has great geographical diversity [13], but in the national context, reference values for Ethiopians have never been established, despite a very few attempts in few localities which showed variation from other countries [14].

For appropriate diagnosis, treatment, and follow-up of patients, correct interpretation of the laboratory results is mandatory since it helps clinicians. This is attained by the knowledge of normal reference intervals that have been established at local setting than using references from western countries which have different climate, socioeconomic status, living style and genetic makeup, and so forth [15]. This study is, therefore, planned to provide normal reference intervals of T lymphocytes subsets and to cells ratio for the population of Gondar, North West Ethiopia.

2. Materials and Methods

2.1. Study Design and Study Subjects

Cross-sectional study was conducted from April to May, 2013, at the voluntary counseling and HIV testing clinic of University of Gondar Hospital and all laboratory investigations were done in the antiretroviral therapy laboratory of the hospital, Gondar town, North West Ethiopia. This laboratory, according to Ethiopian National Accreditation Office (ENAO), which established the Stepwise Laboratory (Quality) Improvement Process towards Accreditation (SLIPTA), has got 3 stars (75–84%) ranked from 5 stars (≥95%). ENAO gives recognition based on progress towards meeting requirements set by international standards and on laboratory performance during the 12 months preceding the SLIPTA audit, relying on complete and accurate data, to improve quality of public health laboratories in developing countries to achieve ISO 15189 standards.

All study participants who were free from clinical disease conditions, looking apparently healthy, whose age groups 18 to 64 years old, who lived in the area at least in the past for six months, being negative for HIV-1/2 antibodies, and having body mass index between 16.5 Kg/M² and 22 Kg/M² were included. The participants giving history of the recent enteric, respiratory infections and malaria and chronic noninfectious illnesses like diabetes mellitus, chronic renal disease, allergies, recent past immunization in the last 6 months, steroid therapy in the past three months, antibiotic usage four weeks prior to enrollment, and blood or blood product transfusion in the past 6 months were excluded. Female participants who were pregnant after being confirmed by human chorionic gonadotropin (hcG) tests were also excluded from the study.

A total of 320 individuals were included based on the recommended guideline of Clinical and Laboratory Standards Institute (CLSI) [21]. Accordingly this CLSI, a priori sampling method was conducted that requires well-defined exclusion and partitioning criteria before the selection of the reference individuals.

2.2. Data Collection and Processing

Prior to actual data collection, the clarity of the tool was assessed using 5% of the total sample size on other study areas. In addition, training about data collection was given for data collectors, two HIV counselor nurses and three laboratory technologists. All specimens from study subjects were handled following the standard operating procedures. Possible diurnal variations for T lymphocyte counts were controlled by collecting blood only at the specified hours in the morning (between 8:30 and 10:30 a.m.). The proper functioning of instruments, laboratory reagents, and technical performance were checked daily using quality control samples before running participant samples and along with participant samples.

Using the semistructured and pretested questionnaire sociodemographic characteristics and relevant clinical data were collected by face-to-face interview from the study participants. Five (5) mL of whole blood for all HIV1/2 antibodies screening , , ,  and to ratio T lymphocytes counts was collected in tripotassium ethylenediaminetetraacetic acid (K₃EDTA) vacutainer tubes.

Participant’s specimen screened for the presence of  HIV antibodies using HIV-1/2 rapid test assay (using KHB, STAT Pack, and UNIGOLD) following the manufacturer’s instruction and the national test algorism. This HIV serology was carried out anonymously with all sociodemographic characteristics. Those confirmed negative for HIV1/2 antibodies women were requested to check their pregnancy by One Step Strip Style hCG Pregnancy Test. Finally, all HIV negative individuals and nonpregnant women samples were assayed for ,  ,  , and CD4 to CD8 ratio T lymphocytes count.

All samples for T lymphocytes count processed and counted within 8 hrs of collection at the ART Laboratory, according to the instructions of the manufacturer. The blood collected with BD vacutainer tubes was well mixed and 50 μL of the whole blood was transferred into monoclonal antibodies reagent tubes for FACSCount analysis to enumerate the T lymphocytes.

In brief, 50 μL of whole blood was mixed with monoclonal antibodies (MAbs) (5 μL of each T lymphocytes reagent tubes) and incubated at room temperature for 15 min in separate tubes and was placed in the dark place. By adding of fluorescence-activated cell sorter lysing solution (50% diethylene glycol and 15% formaldehyde) (Becton Dickinson) erythrocytes were lysed. After vortexing the tubes, it was incubated in the dark at room temperature for 15 minutes. Cells were injected into a “flow cell” which is located in the optical path of a light source, analyzed, and counted using a fluorescence-activated cell sorting count machine (Becton Dickinson FACSCount flow cytometer); here, the cells come in contact with the laser light, which causes the fluorochrome-labeled cells to fluoresce. This fluorescent light provides the necessary information for the instrument to count the cells.

2.3. Data Analysis

Data were entered and cleaned first using Epi-Info version 3.5.1 and then exported to SPSS version 20 for analysis. The mean, median, and standard deviation of normal reference interval values was calculated. Reference interval was determined as 95th percentile of the ordering data. values less than 0.05 were considered statistically significant.

2.4. Ethical Clearance and Consent

Ethical clearance was secured from the ethical review committee of the School of Biomedical and laboratory Science, University of Gondar. Official letter from University of Gondar Teaching Hospital Director office was obtained and submitted to both VCT center and antiretroviral therapy laboratory coordinator. Written informed consent was taken from each study participant. Those participants, who had HIV infection, were referred to the HIV care and treatment clinic for further management after counseling. Female participants who were reactive for hcG test were referred to antenatal clinic for better care.

3. Results

A total of 320 study participants were included in the study with mean age of years old. Out of the total 320 study participants, 161 (50.3%) were men and 159 (49.7%) were women. Men were older than women, with mean ages of years and years, respectively. The majority of the study participants were 224 (70%) single in marital status and were 95 (29.7%) students in their occupational status; concerning educational status most of participants 116 (36.3%) were 9th–12th grades and 292 (91.3%) Amhara ethnic (Table 1). The overall mean, median, and the 95% normal reference interval values for absolute , , and T lymphocyte count and also for absolute to ratio were established for the participants (Table 2).

Table 1: Sociodemographic characteristics of HIV1/2 negative adults who visited VCT in University of Gondar Hospital, Ethiopia, 2013.

Sociodemographic characteristic
Number of participants
Percent (%)

Marital status

    Single
224
70

    Married
48
15

    Divorced
46
15.4

    Widowed
2
0.6

Occupational status

    Student
95
29.7

    Farmer
37
11.6

    Daily labor
36
11.3

    Merchant
31
9.7

    Housewife
24
7.5

    Teacher
7
2.2

    Driver
5
1.6

    Others
85
26.6

Educational status

    Illiterates
50
15.6

    1–8th
94
29.4

    9–12th
116
36.3

    >12th
60
18.8

Ethnic groups

    Amhara
292
91.3

    Kimant
12
3.8

    Oromo
3
0.9

    Tigray
2
0.6

    Others
11
3.4

Table 2: Means, medians, and 95th percentile reference intervals of CD3⁺, CD4⁺, CD8⁺, and CD4 to CD8 ratio of HIV negative adults who visited VCT, University of Gondar Hospital, Ethiopia, 2013.

Participants
Average CD3⁺/L
Absolute CD4⁺/L
Absolute CD8⁺/L
CD4 : CD8 ratio

Male = (161)

    Mean ± SD∗
1567 ± 562
759 ± 252
705 ± 370
1.3 ± 0.5

    Median
1485
737
623
1.23

    95% range
611–2974
265–1685
206–1733
0.4–2.8

Female (159)

    Mean ± SD
1706 ± 547
882 ± 275
739 ± 342
1.34 ± 0.5

    Median
1675
858
667
1.26

    95% range
828–2824
387–1411
241–1667
0.6–2.5

Total (320)

    Mean ± SD
1636 ± 559
820 ± 270
722 ± 356
1.3 ± 0.5

    Median
1574
774
650
1.2

    95% range
655–2823
321–1389
220–1664
0.5–2.52

SD = standard deviation.

T lymphocyte subset values in HIV-1/2 seronegative individuals are reported to be affected by different factors like gender, age, and geographical location worldwide. In this study also as overall the age increases, there was decline in the value of T lymphocytes (Table 3).

Table 3: The mean reference value of T lymphocytes subpopulation/L blood in HIV negative adults who visited VCT, University of Gondar Hospital, Ethiopia by age and sex, 2013.

Age group (yrs.)
Gender

Male
Female
Total

Number tested
Mean CD4⁺
Mean CD8⁺
Mean CD4/CD8
Number tested
Mean CD4⁺
Mean CD8⁺
Mean CD4/CD8
Number tested
Mean CD4⁺
Mean CD8⁺
Mean CD4/CD8

18–25
96
791
735
1.3
122
891
740
1.4
218
847
737
1.3

26–35
46
705
662
1.3
25
884
764
1.3
71
768
698
1.3

36–45
15
761
649
1.4
10
854
721
1.4
25
798
678
1.4

46–60
2
565
876
0.6
2
485
472
1.2
4
525
674
0.9

>60
2
636
534
2
—
—
—
—
2
636
534
2.0

Total
161
759
705
1.3
159
882
739
1.34
320
820
722
1.3

The absolute mean of ( cells/μL) and ( cells/μL) T lymphocytes for men is statistically lower than women ( cells/μL) () and ( cells/μL) (), respectively, but there was no statistically significant difference in the mean absolute count for T lymphocytes () and to ratio of lymphocytes between male and female ().

4. Discussion

The mean and the upper limit reference interval results T lymphocyte counts were higher than the user’s guideline mean: 1206 and (reference interval: 688–1955) cells/μL. The mean of T lymphocyte count for women participants was significantly higher than from those men participants ().

The median (reference interval) of these lymphocytes in women seems slightly greater than the study conducted in other parts of Ethiopian median (reference interval). In addition, median and the upper limit of men T lymphocyte of the current study show a higher result than men participants median and reference interval of their study, as studied by Kassu et al. [16], and lower from the study done in South West Ethiopia median (reference range) 1,643 (760–3,465) by Haileamlak et al. [22]; this could result from the difference of study subject since we used apparently healthy individuals whereas their study groups were clinically assessed specially in the Kassu et al. study. T lymphocytes mean, median, and 95% reference interval of the current study are comparable with the study done in Kenya, median and reference interval [20].

The 95% reference interval for the absolute T lymphocyte count for the participants was lower and a slight wider than the current national guideline for ART users and FACSCount user guideline (reference interval: 470–1298 cells/μL) may be because of racial difference among the study subjects. Results of mean and median values for T lymphocytes were greater than from the result of study done in Akaki factory worker by Tsegaye et al., Addis Ababa, Ethiopia ( cells/μL) and for the present study 95% normal reference interval (321–1389 cells/μL) lower limit nearly lower than there (366–1235 cells/μL) [14] could be due to geographical difference. T lymphocytes count was consistent with the study done in Tanzania [10] and Botswana blood donors [23].

However, the values of T lymphocytes mean, median, and 95% normal reference interval were lower than from the study done in Kenya [20], Uganda (mean: 938, reference interval: 418–2105 cells/μL) [8], Central Africa Republic study done by Menard et al. (mean: 940, median: 912, reference interval: 386–1454 cells/μL) [17], healthy Nigerian adults done (mean: 847, reference interval: 365–1571 cells/μL) [11]; this was again maybe by different geographical location.

The absolute median count of T lymphocytes for men (737 cells/μL) and women (858 cells/μL) was statistically different in the present study and lower than the study done by Torres et al. in the two regions of Brazil blood donors, that is, the study in Bahia/Pará men absolute count (897/768 cells/μL) and for women (1032/802 cells/μL) [7] maybe because of the use of apparently healthy study subjects in the current study.

The overall mean and median T lymphocyte counts show similarity from the study done by Tsegaye et al. so far other parts of Ethiopia. T lymphocyte counts show great difference from the FACSCount user guideline (mean: 346, reference interval: 208–796); it might be because of the large sample size used in the present study and/or racial diversity. Women mean and median of T lymphocytes counts were higher than men but it is not statistically significant ().

Similarities had also observed between men and women of the current results (women’s median value: 667, 95% normal reference interval: 241–1667) (men’s median value: 623, 95% normal reference interval: 206–1733 cells/μL) from the previous study done by Kassu et al. in Ethiopia (women median value: 617, range 258–1301 cells/μL) (men’s median value 619, reference range: 249–1,933 cells/μL) from Akaki, but the upper limit of 95% normal reference interval for men (206–1733 cells/μL) was completely higher than the values of men those found in Wonji (range: 180–1253 cells/μL) [16]; probably it could be environmental factors (Table 4).

Table 4: Gender based 95% reference interval of HIV negative adults visited VCT, University of Gondar Hospital, Ethiopia, 2013, as compared with other countries.

Parameter
Current study
Ethiopia
CAR
Nigeria
India
Switzerland

Males

CD3⁺/L
611–2974
759–2742
NA
NA
NA
521–1772

CD4⁺/L
265–1685  
355–1213∗
391–1145
380–1617
351–1455
383–1347
336–1126

CD8⁺/L
206–1733
249–1933
267–1545
155–863
NA
125–780

CD4 : CD8 ratio/L
0.4–2.8
0.41–2.57
0.34–1.88
0.7–5.1
NA
0.9–6.0

Females

CD3⁺/L
828–2824
741–2329
NA
NA
NA
595–1861

CD4⁺/L
387–1411  
470–1298∗
386–1355
386–1454
383–1654
448–1593
314–1270

CD8⁺/L
241–1667
258–1301
226–1225
133–919
NA
147–836

CD4 : CD8 ratio/L
0.6–2.50
0.52–2.60
0.6–2.27
0.8–5.8
NA
1.0–4.9

References in numbers

[16]
[17]
[11]
[18]
[19]

User’s guideline values, NA = not available.

The absolute T lymphocytes mean, median, and the 95% normal reference interval value for the current study were also greater than the studies conducted from Switzerland by Bisset et al. (median: 347, range: 137–823 cells/μL) [19], Shanghai, China (mean: 539, median: 503, range: 336–780 cells/μL) [24], Asian population (mean: 642, median: 616, reference range: 243–1206 cells/μL) [25]; the difference could be on our apparently healthy study population whereas they used only blood donors especially in Asian population and Switzerland studies, we used more numbers of study subjects in the current study but the study done in Switzerland used 70 individual healthy blood donors, or it may be due to the high parasitic prevalence and high microbial infection in the local area which can contribute to the increased number of absolute T lymphocyte counts, since once T lymphocytes are activated, they will have long life span.

Absolute to ratio T lymphocytes mean, median, and 95% normal reference interval were lower than from women’s, but the difference was not statistically significant ().

Furthermore the result of this gender specific ratio in the current study (males median: 1.23, normal reference interval: 0.4–2.8) (females median: 1.26, normal reference interval: 0.6–2.5) is in line with the study conducted Akaki (males median: 1.10, reference range: 0.41–2.57) (females median: 1.2, reference range: 0.52–2.60), and also Wonji (males median 1.4, range: 0.6–2.80), south east of Ethiopia [16].

The gender specific result to ratio (males mean: , normal reference interval: 0.4–2.8) (females mean: , normal reference interval: 0.6–2.5) of the current study was lower than from the study done in Uganda (males mean: 1.47, range: 0.54–3.94) (females mean: 1.46, range: 0.48–4.41) [8].

Overall the result of CD4 to CD8 T lymphocytes ratio in the current study was lower than the study from Kenya [20], Tanzania [10], Nigeria [11], and India [18]. As compared to the study done in Switzerland [19] and Asian population [25], the current results also show great variation (Table 5), since our life style exposed to different infectious organism and the high prevalence of infection for the current study have been implicated as possible explanation to reduce CD4/CD8 T-cell ratios.

Table 5: The overall 95% normal reference interval for Tlymphocytes in HIV negative adults in the current study as compared to other African countries.

Parameter
User’s guideline
Current study
Previous study in Ethiopia
Kenya
Tanzania
Uganda
Nigeria

CD3⁺/L
688–1955
655–2823
NA
744–2634
NA
NA
NA

CD4⁺/L
500–1300
321–1389
366–1235
421–1550
312–1367
418–2105
365–1571

CD8⁺/L
208–796
220–1664
311–1618
210–1081
168–996
256–1619
145–884

CD4 : CD8 ratio/L
0.83–6.10
0.5–2.5
0.4–2.4
0.9–3.3
1.1–2.5
0.52–4.1
0.5–5.3

References in numbers

[14]
[20]
[10]
[8]
[11]

NA = not available.

5. Conclusions

The overall T lymphocytes reference values were high and its interval was very wide.

The mean and 95% normal reference interval values for absolute T lymphocyte strength the earlier reports done from Ethiopia and other African studies; it was low T lymphocyte. In general, in this study, very high T lymphocytes counts and very low to ratio were observed; so the current reference interval results should be applicable only for the study area. Since the reference value for T lymphocyte is low in the current study from the national reference and user guidelines also, physician should use a higher T lymphocytes cutoff values for initiation of ART drugs and highly recommended to establish local reference interval for each laboratory.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Addisu Gize, Biniam Mathewos, and Beyene Moges conceived the study and participated in the design and data analysis. Meseret Workineh involved in data acquisition and laboratory work and drafted the paper. Lealem Gedefaw critically reviewed the paper. All authors read and approved the paper.

Acknowledgments

The authors would like to thank staff members of Gondar University Hospital, particularly the Medical laboratory staff for their cooperation during data collection. They are grateful to the study participants. This study was financially supported by University of Gondar.

References

A. Santagostino, G. Garbaccio, A. Pistorio et al., “An italian national multicenter study for the definition of reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults,” Haematologica, vol. 84, no. 6, pp. 499–504, 1999.

R. M. Hoffman, B. D. Jamieson, R. J. Bosch et al., “Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals,” Journal of Clinical Immunology, vol. 31, no. 5, pp. 873–881, 2011.

M. Bofill, G. Janossy, C. A. Lee et al., “Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis,” Clinical and Experimental Immunology, vol. 88, no. 2, pp. 243–252, 1992.

C. Mair, S. E. Hawes, H. D. Agne et al., “Factors associated with CD4 lymphocyte counts in HIV-negative Senegalese individuals,” Clinical and Experimental Immunology, vol. 151, no. 3, pp. 432–440, 2008.

D. Lawrie, L. M. Coetzee, P. Becker, J. Mahlangu, W. Stevens, and D. K. Glencross, “Local reference ranges for full blood count and CD4 lymphocyte count testing,” South African Medical Journal, vol. 99, no. 4, pp. 243–248, 2009.

M. R. Thakar, P. R. Abraham, S. Arora, et al., “Establishment of reference CD4+ T cell values for adult Indian population,” AIDS Research and Therapy, vol. 8, no. 1, article 35, 2011.

A. J. L. Torres, A. L. D. Angelo, E. M. Netto et al., “Reference range for T lymphocytes populations in blood donors from two different regions in Brazil,” Brazilian Journal of Infectious Diseases, vol. 13, no. 3, pp. 221–225, 2009.

S. Nanzigu, P. Waako, M. Petzold et al., “CD4-T-lymphocyte reference ranges in Uganda and its influencing factors,” Laboratory Medicine, vol. 42, no. 2, pp. 94–101, 2011.

A. Tsegaye, D. Wolday, S. Otto et al., “Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians,” Clinical Immunology, vol. 109, no. 3, pp. 338–346, 2003.

B. J. Ngowi, S. G. Mfinanga, J. N. Bruun, and O. Morkve, “Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania.,” BMC infectious diseases, vol. 9, p. 1, 2009.

D. K. Oladepo, E. O. Idigbe, R. A. Audu et al., “Establishment of reference values of CD4 and CD8 lymphocyte subsets in healthy Nigerian adults,” Clinical and Vaccine Immunology, vol. 16, no. 9, pp. 1374–1377, 2009.

I. M. Kueviakoe, A. Y. Segbena, H. Jouault, A. Vovor, and M. Imbert, “Hematological reference values for healthy adults in togo,” ISRN Hematology, vol. 2011, Article ID 736062, 5 pages, 2011.

Ethiopia Demographic and Health Survey, Central Statistical Agency Addis Ababa (Ethiopia) and ICF International, Calverton, Md, USA, 2012.

A. Tsegaye, T. Messele, T. Tilahun et al., “Immunohematological reference ranges for adult ethiopians,” Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 3, pp. 410–414, 1999.

E. S. Lugada, J. Mermin, F. Kaharuza, et al., “Population-based hematologic and immunologic reference values for a healthy Ugandan population,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 1, pp. 29–34, 2004.

A. Kassu, A. Tsegaye, B. Petros et al., “Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales,” Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 6, pp. 1171–1176, 2001.

D. Menard, M. J. Mandeng, M. B. Tothy, E. K. Kelembho, G. Gresenguet, and A. Talarmin, “Immunohematological reference ranges for adults from the Central African Republic,” Clinical and Vaccine Immunology, vol. 10, no. 3, pp. 443–445, 2003.

K. G. Murugavel, P. Balakrishnan, J. Mohanakrishnan et al., “Establishment of T-lymphocyte subset reference intervals in a healthy adult population in Chennai, India,” Indian Journal of Medical Research, vol. 129, no. 1, pp. 59–63, 2009.

L. R. Bisset, T. L. Lung, M. Kaelin, E. Ludwig, and R. W. Dubs, “Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland,” European Journal of Haematology, vol. 72, no. 3, pp. 203–212, 2004.

R. S. Kibaya, C. T. Bautista, F. K. Sawe et al., “Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya,” PLoS ONE, vol. 3, no. 10, Article ID e3327, 2008.

NCCLS, How to Define and Determine Reference Intervals in the Clinical Laboratory, Approved Guideline, National Committee for Clinical and Laboratory Standard Document C28-A2, NCCLS, 2nd edition, 2000.

A. Haileamlak, A. T. Muluneh, F. Alemseged, et al., “Hematoimmunological profile at Gilgel Gibe field research center, southwest Ethiopia,” Ethiopian Journal of Health Sciences, vol. 22, pp. 39–50, 2012.

H. Bussmann, C. W. Wester, K. V. Masupu, et al., “Low CD4⁺ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 5, pp. 930–935, 2004.

W. Jiang, L. Kang, H.-Z. Lu et al., “Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 4, pp. 811–813, 2004.

W. J. Chng, G. B. Tan, and P. Kuperan, “Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and eace and comparison with other published studies,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 1, pp. 168–173, 2004.